Brief: First Wave Biopharma Says On September 13, Entered Into A License Agreement With Sanofi

GridAI Technologies

14/09/2023 12:22

Sept 14 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA INC - ON SEPTEMBER 13, ENTERED INTO A
LICENSE AGREEMENT WITH SANOFI
    * FIRST WAVE BIOPHARMA - UNDER TERMS, SANOFI TO BE ELIGIBLE
TO GET
UP TO $46 MILLION IN POTENTIAL DEVELOPMENT AND REGULATORY
MILESTONE PAYMENTS
    * FIRST WAVE BIOPHARMA INC - WILL PAY SANOFI AN UPFRONT
PAYMENT OF
$500,000 WITHIN THIRTY BUSINESS DAYS OF DATE OF LICENSE
AGREEMENT
    * FIRST WAVE BIOPHARMA INC - UNDER TERMS, SANOFI WILL BE
ELIGIBLE
TO RECEIVE UP TO $235 MILLION IN POTENTIAL COMMERCIAL MILESTONE
PAYMENTS
    * FIRST WAVE BIOPHARMA INC - SANOFI WILL ALSO HAVE A RIGHT
OF
FIRST REFUSAL WITH RESPECT TO CAPESEROD OUT-LICENSING
TRANSACTIONS

Source text for Eikon:  ID: 
Further company coverage:  FWBI.O 

 ((Reuters.Brief@thomsonreuters.com;))